Unapproved peptide therapies and dermatologic care: Ethical boundaries in a gray-market era
JAAD International · 2026-12 · 29 · 79-80
DOI: 10.1016/j.jdin.2026.09.006 ↗Kurz gefasst
Editorial in der Zeitschrift JAAD International, 2026-12. Verfasst von Tarek Zieneldien und 2 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins University School of Medicine, Baltimore, Maryland. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Johns Hopkins University School of Medicine, Baltimore, Maryland.
- Department of Dermatology, University of Connecticut School of Medicine, Farmington, Connecticut.
- Department of Dermatology, University of Florida College of Medicine, Gainesville, Florida.
Zitieren
APA
Zieneldien, T., Ma, S., & Grant-Kels, J. M. (2026). Unapproved peptide therapies and dermatologic care: Ethical boundaries in a gray-market era. JAAD International, 29, 79-80. https://doi.org/10.1016/j.jdin.2026.09.006
Vancouver
Zieneldien T, Ma S, Grant-Kels JM. Unapproved peptide therapies and dermatologic care: Ethical boundaries in a gray-market era. JAAD International. 2026;29:79-80. doi:10.1016/j.jdin.2026.09.006
BibTeX
@article{Zieneldien2026,
author = {Zieneldien, Tarek and Ma, Sophia and Grant-Kels, Jane M},
title = {Unapproved peptide therapies and dermatologic care: Ethical boundaries in a gray-market era},
journal = {JAAD International},
year = {2026},
volume = {29},
pages = {79--80},
doi = {10.1016/j.jdin.2026.09.006}
}
EUVIMED